Rheumatology

New research links altered monounsaturated fatty acids, especially oleic acid, to disease activity and adiposity in people with rheumatoid arthritis.

New real-world data show tocilizumab steadied lung function and eased skin, joint, and vascular disease across nearly 200 systemic sclerosis patients.

An early study positions a VAP-1-targeting PET tracer as an inflammation-specific biomarker for tracking activity in giant cell arteritis.

Elevated S1P levels in psoriatic arthritis were associated with disease progression, enthesitis, and structural damage.

Site-specific inflammation may be predetermined during fetal tissue development, according to a new study from the University of Oxford.

Women with systemic sclerosis face increased risks at pregnancy and a greater likelihood of reproductive hormone imbalances and sexual dysfunction, new research has found.

Classification criteria and recommendations for the diagnosis and clinical management of spondyloarthritis have been updated and were presented at EULAR 2026.

Researchers have highlighted, at EULAR 2026, different pathways through which the rheumatology patient’s experience can be enhanced.